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Abstract
Modelling the transmission dynamics of Multi-strains
Influenza with Vaccination and Antiviral Treatment
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Department of Mathematical Sciences,
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Private Bag X1, Matieland 7602, South Africa.
Thesis: MScMath (Biomathematics)
December 2011
Recently, new strains of influenza such as bird flu and swine flu have emerged.
These strains have the capacity to infect people on a quite large scale and are
characterized by their resistance to existing influenza treatment and their high
mortality rates.
In this thesis, we consider two models for influenza transmission dynamics that
include both sensitive and resistant strains and accounts for disease induced
mortality.
ii
Stellenbosch University http://scholar.sun.ac.za
ABSTRACT iii
The first model allows for immigration/migration and does not include any
control measure. The second one explores the effects of vaccination and treat-
ment of the sensitive strain but ignores immigration/migration.
We studied the two models mathematically and numerically. We started with
the model without any control measures; we calculated the basic reproductive
numbers, determined the equilibrium points and investigated their stability.
Our analysis showed that when the basic reproduction numbers of both strains
are less than one then the two strains will die out. When at least one of the
basic reproduction numbers is greater than one, then the strain with the higher
basic reproduction number is the one that will persist. Numerical simulations
were carried out to confirm the stability results and a bifurcation diagram
was given. We also studied numerically the impact of the mortality rate of
influenza on the dynamics of the disease. Especially, we investigated the effect
of the mortality rate on the time needed for the pandemic to reach its peak,
the value at the peak for each strain and, when eradication is possible, the
time it takes for the disease to be eradicated.
For the model with control, we also calculated the control reproductive number
and the equilibrium points. The stability analysis was carried out numerically
and bifurcation diagrams with vaccination and treatment parameters were
given to determine the regions where eradication of the disease is possible.
Our results suggest that in the presence of a resistant strain, treating more
infected individuals will not eradicate the disease as the resistant strain will
always persist. In such a case vaccination and antiviral treatment should be
implemented simultaneously.
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Chapter 1
Introduction
1.1 Overview of influenza dynamics
Influenza is a respiratory infection in mammals and birds. It is caused by an
RNA virus in the family Orthomyxoviridae family [14, 10]. Human influenza
viruses can be passed to other people by exposure to infected droplets expelled
by coughing or sneezing that can be inhaled, or that can contaminate hands
or surfaces. Individuals incubate the virus for roughly one to three days before
becoming infectious after initial infection [24]. Infectiousness can precede clin-
ical disease by approximately one day. The infectious period is typically three
to six days, whereas the duration of the disease is typically two to seven days.
Most individuals recover from influenza and are believed to retain lifelong im-
munity to strains closely related to the infecting strain. The virus is divided
into three main types (A, B and C), which are distinguished by differences
in two major internal proteins [24]. Influenza virus type A is the most sig-
nificant and interesting from an epidemiological, ecological and evolutionary
1
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION 2
Figure 1.1: Types and known strains of human influenza viruses [23].
standpoint because it is found in a wide variety of bird and mammal species
and can undergo major shifts in immunological properties. Type B is largely
confined to humans and is an important cause of morbidity. Little is known
about type C, which is not an important source of morbidity. Surprisingly little
is known about the transmission of influenza, and the importance of airborne
transmission relative to droplet transmission remains controversial [24].
Currently there are two subtypes of type A influenza virus circulating in hu-
mans, namely, H1N1 and H3N2 [23]. The H1N1 subtype of influenza which
is commonly known as swine flu is caused by H1N1 influenza A virus, is a
combination of swine, avian and human influenza viruses. The symptoms of
H1N1 are usually mild, but they can become severe, leading to pneumonia or
respiratory failure. The H3N1 subtype of influenza is also a strain of the type
A influenza virus that can cause illness in humans. The severity of symptoms
can vary but usually involves respiratory and constitutional (e.g. headache,
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Figure 1.2: "U-" and "W-" shaped combined influenza and pneumonia mortal-
ity, by age at death, per 100 persons in each age group, United States, 1911-1918.
Influenza- and pneumonia specific death rates are plotted for the inter-pandemic
years 1911-1917(dashed line) and for the pandemic year 1918(solid line) [1].
aching muscles) symptoms [17]. Influenza has been a major cause of morbid-
ity and mortality. Three influenza pandemics that lead to the death of 40-50
million people. Fortunately, subsequent pandemics of the twentieth century
were not as severe as the Spanish Flu. For instance, the Asian Flu of 1957
killed about 2 million people while the Hong Kong Flu (1968) killed around 1
million people [1].
Influenza epidemics can seriously affect all age groups annually, but the highest
risk of complications occur among children younger than age two, adults aged
65 or older, pregnant women and people of any age with certain medical con-
ditions, such as chronic heart, lung, kidney, liver, blood or metabolic diseases
such as diabetes, or weakened immune system [24, 17]. The curve of influenza
deaths by age at death has historically, for at least 150 years, been U-shaped
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as in figure (1.2), exhibiting mortality peaks in the very young and the very
old, with a comparatively low frequency of death at all ages in between.
As of June 2010, worldwide more than 214 countries and communities have re-
ported laboratory confirmed cases of pandemic influenza H1N1 2009, including
over 18, 209 deaths [3].
National authorities confirmed deaths of 14,286 in 2009 worldwide. World
Health Organization (WHO) states that mortality caused by the new H1N1
strain is unreported. The Centre for Disease Control (CDC) estimated 9,820
death caused by swine flu by November 2009 in the United States of America
[12].
Influenza can cause serious public health and economic problems [24, 17]. In
developed countries, epidemics can result in high levels of worker absenteeism
and productivity losses. In communities, clinics and hospitals can be over-
whelmed when large numbers of sick people appear for treatment during peak
illness periods. While most people recover from influenza, there are large
numbers of people who need hospital treatment and many who die from the
disease every year. Unfortunately, little is known about the effects of influenza
epidemics in developing countries such as South Africa.
1.2 Vaccination and antiviral treatment for
influenza
Human influenza vaccination was first introduced in the 1940’s, representing
a breakthrough in the struggle against influenza. In 1942, clinical trials car-
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Figure 1.3: Influenza virus [23].
ried out by the US Army confirmed the usefulness of vaccination in reducing
morbidity and mortality due to influenza [7]. The failure of current influenza
vaccines to protect all vaccine recipients warrants the determination of condi-
tions necessary for a substantial reduction and possible eradication of influenza
infection [4].
Influenza vaccination is the most effective method for preventing influenza
virus infection and its potentially severe complications [4]. Influenza immu-
nization efforts are focused primarily on providing vaccination to persons at
risk for influenza complications and to contacts of these persons. Influenza
vaccine may be administered to any person aged less than 6 months to reduce
the likelihood of becoming ill with influenza or of transmitting influenza to oth-
ers; if vaccine supply is limited, priority for vaccination is typically assigned to
persons in specific groups and of specific ages who are, or are contacts of, per-
sons at higher risk for influenza complications. Trivalent Inactivated Influenza
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Vaccine (TIV) may be used for any person aged less than 6 months, including
those with high-risk conditions. Live, Attenuated Influenza Vaccine (LAIV) is
currently approved only for use among healthy, nonpregnant persons aged 5-49
years. Because influenza viruses undergo frequent antigenic change, persons
recommended for vaccination must receive an annual vaccination against the
influenza viruses currently in circulation.
Although vaccination has been an effective strategy against influenza infection,
current preventive vaccines consisting of inactivated virions do not protect all
vaccine recipients equally [4]. Vaccine-based protection is dependent on the
immune status of the recipient. Typically, influenza vaccines protect 70%−90%
of healthy young adults and as low as 30% − 40% of the elderly and others
with weakened immune systems such as HIV-infected or immuno-suppressed
transplant patients. Furthermore, due to the seasonal drift in the viral genome,
annual vaccination against the influenza virus strains anticipated to be in
circulation during the upcoming season is necessary to prevent new infections
and subsequent outbreaks.
Although vaccination coverage has increased in recent years for many groups
recommended for routine vaccination, coverage remains unacceptably low.
Strategies to improve vaccination coverage, including use of reminder or re-
call systems and standing order programs should be implemented or expanded
[11]. Human influenza treatment includes a range of medications and therapies
that are used in response to influenza [16]. Treatments may either directly tar-
get the influenza virus itself, or simply offer relief to symptoms of the disease,
while the body’s own immune system works to recover from infection. The
two main classes of antiviral drugs used against influenza are neuraminidase
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inhibitors, such as zanamivir and oseltamivir, or inhibitors of the viral M2
protein, such as amantadine and rimantadine. These drugs can reduce the
severity of symptoms if taken soon after infection and can also be taken to de-
crease the risk of infection. The failure of current influenza vaccines to protect
all vaccine recipients warrants the determination of conditions necessary for a
substantial reduction and possible eradication of influenza infection [4].
Antiviral medications are complementary to vaccination and are effective when
administered as treatment and chemoprophylaxis after an exposure to in-
fluenza virus [11].
1.3 Motivation of the study
Because there is the high risk for the influenza pandemic and large number of
deaths associated with influenza, it is imperative to increase our understand-
ing of the influenza disease dynamics. Mathematical models have provided a
useful tool to gain insights into the transmission and control of the disease
[18]. These insights can potentially help us assess the effectiveness and im-
plications of various preventive and control strategies. They also allow us to
investigate hypotheses about the mechanisms responsible for epidemics and to
reject hypotheses that yield predictions that are inconsistent with documented
epidemic patterns.
Historically, models with different strains of influenza virus have been studied,
but most of them have considered sensitive and resistant strains without tak-
ing into consideration that infected individuals can die due to influenza, for
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instance, swine flu has shown a very high mortality for the past years. In this
study we consider a model that includes a strain that induces a relatively high
mortality and may be drug resistant. The model will be used to determine
minimum proportion of individuals to be treated and vaccinated in order to
eradicate the disease.
1.4 Overall aim of the study
To gain more insights about the impact of antiviral treatment and vaccination
in eradicating the spread of influenza virus among human population.
1.5 Objectives of the study
• To determine the potential impact of antiviral treatment and vaccination
for sensitive and resistant strains of the influenza virus.
• To determine if the use of antiviral treatment reduces the size or delays
the peak of the pandemic.
• To compare the influenza transmission dynamics when control measures
are implemented and when they are not implemented.
• To inform and assist policy-makers in designing proper interventions and
targeting treatment resources for maximum effectiveness.
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1.6 Methodology
We study two compartmental models that describe the transmission dynamics
of influenza virus among the human population. The first model represents
the transmission dynamics of influenza virus when the control measures are
not implemented. The last model is the extension of the first one whereby we
incorporate disease induces mortality and resistant strain. The models will be
studied both analytical and numerically.
Thesis outline
• Chapter 1 provides overview of influenza virus, vaccination and intiviral
treatment for influenza.
• Chapter 2 provides review of several recent studies on influenza that stud-
ied different influenza prevention and control measures including vacci-
nation, antiviral treatment, quarantine, isolations and media coverage.
• Chapter 3 provides an SIR model that describes influenza transmission
dynamics where control measures are not implemented and it is the mod-
ification of the model in [13] by Zhen Jin and his colleagues.
• Chapter 4 provides the main model of our study which represents in-
fluenza transmission dynamics where control measures are implemented.
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Chapter 2
Literature Review
2.1 Influenza models
Mathematical models have been extremely useful in understanding the trans-
mission dynamics of influenza. They have been providing assistance in eval-
uating the potential effectiveness of public health interventions in controlling
pandemics of varying severity. Severity is defined by the value of R0 (the basic
reproduction number). They have also been used for the development and im-
plementation of infection control policies to combat outbreaks and epidemics
of communicable viral diseases such as influenza.
Several recent studies on influenza modelling have focused on the influence of
prevention and control measures including vaccination, antiviral use, quaran-
tine, and isolations [18, 15]. These models have provided useful information
about the impact of various control measures in the disease dynamics. How-
ever, most of these models have considered either vaccination or antiviral use
10
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alone, and vaccination and antiviral treatment. Kermack and McKendrick de-
veloped the first Susceptible-Infectious-Recovered (SIR) mathematical model
that could be used to describe an influenza epidemic [8]. The is SIR model
has been used as a basis for all influenza models. The simplest extension to
the SIR model includes demographics, specifically inflow and outflow of indi-
viduals into the population. Analysis of this demographic model shows that
influenza epidemics can be expected to cycle, with damped oscillations, and
reach a stable endemic level. In [9, 20] the SIR model was modified to include
seasonality. This gave rise to a model that captured the sustained cycles of
influenza epidemics. The SIR model has also been extended in order to pre-
dict the spatial dynamics of an influenza epidemic. The first spatialtemporal
model of influenza was developed in the late 1960s by Rvachev [19]. He con-
nected a series of SIR models in order to construct a network model of linked
epidemics. He then modelled the geographic spread of influenza in the former
Soviet Union by using travel data to estimate the degree of linkage between
epidemics in major cities.
In the 1980s, Rvachev and his colleagues Baroyan and Longini extended his
network model by including biomedical interventions such as vaccination, pro-
phylactic treatment with antivirals, and therapeutic treatment [8]. It has been
shown that once interventions are included in the model, a Reproduction Con-
trol Number (RC) can be determined. RC is defined as the average number
of new infections that one infectious case generates, in an entirely susceptible
population when an intervention is in place, during the time they are infec-
tious. The value of RC will depends on both the strength of the intervention
and the severity of the epidemic in the absence of the intervention (R0). The
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quantity RC will always be less than R0, but if RC < 1, the intervention will
cause the epidemic to die out, whereas if RC > 1 the intervention will only
reduce the severity of the epidemic.
In [21], a deterministic transmission and vaccination model was studied to
investigate the effects of media coverage on the transmission dynamics of in-
fluenza. The model included the effect of media coverage on reporting the num-
ber of infections as well as the number of individuals successfully vaccinated.
The have used the basic reproduction number to discuss the local stability of
the disease-free equilibrium. They have also investigated the impact of costs
that can be incurred, which include vaccination, education, implementation
and campaigns on media coverage using optimal control theory. Their model
shown that the media trigger a vaccinating panic if the vaccine is imperfect
and simplified messages result in the vaccinated mixing with the infectives
without regard to disease rick. Therefore the effects of media on an outbreak
are complex. Simplified understanding of disease epidemiology, propagated
through media sound-bites, may make the disease significantly worse.
In [5], a stochastic model of pandemic influenza was used to investigate re-
alistic strategies that can be used in reaction to developing outbreaks. The
model was calibrated to documented illness attack rates and basic reproduc-
tive number (R0) estimates, and constructed to represent a typical mid-sized
North American city. The model predicted an average illness attack rate of
34.1% in the absence of intervention, with total costs associated with mor-
bidity and mortality of US dollars 81 million for such a city. Attack rates
and economic costs can be reduced to 5.4% and US dollars 37 million, respec-
tively, when low-coverage reactive vaccination and limited antiviral use are
Stellenbosch University http://scholar.sun.ac.za
CHAPTER 2. LITERATURE REVIEW 13
combined with practical, minimally disruptive social distancing strategies, in-
cluding short-term, as-needed closure of individual schools, even when vaccine
supply-chain-related delays occur. Results improve with increasing vaccination
coverage and higher vaccine efficacy.
In [4] a deterministic compartmental mathematical model was constructed
to study the transmission dynamics of influenza. The model was analysed
qualitatively to determine criteria for control of an influenza epidemic and was
used to compute the threshold vaccination rate necessary for community-wide
control of influenza. Using two specific populations of similar sizes, an office
and a personal care home, the model showed that the spread of influenza can
be controlled if the combined effect of the vaccine efficacy and vaccination rate
reaches a threshold determined by the duration of infectiousness and the rate
of contact between infected and susceptible individuals .
In [15] a deterministic compartmental model of the transmission of oseltamivir
sensitive and resistant influenza infections during a pandemic was designed
and analysed. The model described a homogeneous population of pandemic
influenza and the control measures prophylaxis and treatment. Vital dynamics
such as births and deaths were not taken into consideration. The model pre-
dicted that even if antiviral treatment or prophylaxis lead to the emergence of
a transmissible resistant strain in as few as 1 in 50,000 treated persons and 1 in
500,000 prophylaxed persons, widespread use of antivirals may strongly pro-
mote the spread of resistant strains at the population level [15]. On the other
hand, even in circumstances in which a resistant strain spreads widely, the use
of antivirals may significantly delay and reduce the total size of the pandemic.
If resistant strains carry some fitness cost, then, despite widespread emergence
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of resistance, antivirals could slow pandemic spread by months or more, and
buy time for vaccine development. This delay would be prolonged by non-
drug control measures such as social distancing that reduce transmission, or
use of a stockpiled suboptimal vaccine. Surprisingly, the model suggested that
such non-drug control measures would increase the proportion of the epidemic
caused by resistant strains. Their model suggested that benefit of antiviral
drug use to control an influenza pandemic may be reduced, although not com-
pletely offset, by drug resistant in the virus. Therefore the risk of resistance
should be considered in pandemic planning and monitored closely during a
pandemic.
Zhipeng and Zhilan [18] adapted a similar structure as that in [15]. They
introduced a vaccinated class, included vital dynamics, neglected prophylaxis
and considered only drug treatment. The main purpose of their model was to
explore the interaction between vaccination and drug use. They found that
higher levels of treatment may lead to an increase of epidemic size, and the
extend to which this occurs depends on other factors such as the rates of
vaccination and resistance development. This simply implies that treatment
should be implemented appropriately.
Summary
In this chapter we reviewed several recent studies on the influence of differ-
ent influenza prevention and control measures including vaccination, antiviral
treatment, quarantine, isolations and media coverage. However, in this study
we will only consider the use of antiviral treatment and vaccination as the con-
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trol measures in order to gain more insights on the implementation of control
measures.
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Chapter 3
Influenza model without control
measures
In this chapter we consider a compartmental model that describes the trans-
mission dynamics of influenza, where control measures such as quarantine,
vaccination and treatment are not implemented. We consider the resistant
and sensitive strains, and recruitment into each class. This model is a slight
modification of the model in [13], whereby only the transmission dynamics
of influenza between susceptible, exposed, infected and recovered individuals
were considered. This model accounts for resistant strains and emergency
strain that may cause death.
Since in this chapter we are not considering any treatment, we should refer to
the two strains as sensitive and resistant strains, we could have called them
just strain 1 and 2, but since we will introduce treatment in Chapter 4 and for
notations convenience we refer them as sensitive (s) and resistant (r) strains.
16
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3.1 Model formulation
The compartmental model (3.1) describes the flow of four different popula-
tion classes. Let N denote the total population size. We divided N into four
disjoint classes: susceptible individuals (S), individuals infected with the sensi-
tive strain (Is), individuals infected with the resistant strain (Ir) and recovered
individuals (R). Then the total population is given by
N = S + Is + Ir +R.
Individuals are recruited into the susceptible class at a rate Λ either through
birth or immigration. Susceptible individuals either die due to natural causes
at a rate µ or progress to the class of individuals infected with the resistant and
sensitive strains at the rates λs and λr respectively. Infected individuals in the
Ij(j = r, s) class recover at a rate kj. The model also consider immigration by
considering a constant rate of individuals moving into (or out of) the infected
individuals classes and recover class.
The model equations are as follows
dS
dt
= Λ− µS − λsS − λrS,
dIs
dt
= Λs + λsS − (µ+ ds + ks)Is,
dIr
dt
= Λr + λrS − (µ+ dr + kr)Ir,
dR
dt
= ΛR + ksIs + krIr − µR
(3.1.1)
where λs = βsIsN and λr =
βrIr
N
with N = S + Is + Ir +R.
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Figure 3.1: Flow chart illustrating the flow of individuals between the S, Is, Ir, R
classes.
3.2 Positivity of solutions
Since the model system (3.1.1) describes the influenza transmission dynamics
among humans, we need to show that it is biological feasible. We have the
following theorem:
Proposition 3.2.1. If S(0) > 0, Is(0) > 0, Ir(0) > 0, R(0) > 0, then the cor-
responding solution (S(t), Is(t), Ir(t), R(t)) of system (3.1.1) is positive. Fur-
thermore, the region
D =
{
(S, Is, Ir, R) ∈ R4+ : S + Is + Ir +R ≤
Λ + Λs + Λr + ΛR
µ
}
is positively invariant, that is, all solutions starting in D will stay in D for all
t ≥ 0. We assume that Λ,Λs,Λr,ΛR ≥ 0
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Table 3.1: Description of parameters and variables for the model without control
measures
Parameter/Variable Description
S Susceptible individuals.
Is Individuals infected with sensitive strain.
Ir Individuals infected with resistant strain.
R Recovery individuals.
Λ Recruitment rate of susceptible individuals either through birth
or immigration.
Λs Recruitment rate of individuals infected with sensitive strain.
Λr Recruitment rate of individuals infected with resistant strain.
ΛR Recruitment rate of recovered individuals.
µ Natural death rate.
ds Disease induced death rate of individuals infected with sensitive strain.
dr Disease induced death rate of individuals infected with resistant strain.
ks Recovery rate of individuals infected with sensitive strain.
kr Recovery rate of individuals infected with resistant strain.
βs Transmission rate of individuals infected with sensitive strain.
βr Transmission rate of individuals infected with resistant strain.
Proof. Let tmax be the upper bound of the maximum interval corresponding
to the solution (S(t), Is(t), Ir(t), R(t)). To show that the solution is positive
and bounded in [0,+∞[, it is sufficient to show the positivity and boundedness
result in [0, tmax[.
Let
t1 = sup {0 ≤ t < tmax : S(τ) > 0, Is(τ) > 0, Ir(τ) > 0, R(τ) > 0 for all τ in [0, t]} .
Since S(0) > 0, Is(0) > 0, Ir(0) > 0 and R(0) > 0 are positive then t1 > 0.
Using the variation of constants formula, we get
S(t1) = U(t1, 0)S(0) + Λ
N(t)
∫ t1
0
U(t1, z) > 0,
where U (t1, z) = exp
(
− ∫ t1
z
(µ+ λs + λr) (α) dα
)
.
Similarly, we can show that Is(t1) > 0, Ir(t1) > 0 and R(t1) > 0. This contra-
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dicts the fact that at least one of the variables must be equal to zero at t1.
Hence t1 = tmax. This concludes the prove of positivity of solutions.
Next, we prove the boundedness of solutions. Assume the initial condition
X(0) = (S(0), Is(0), Ir(0), R(0)) ∈ D , then the corresponding solution of the
model system (3.1.1) exists at all time t < tmax. We need to show that any
solution X(t) with the initial condition in D is bounded and satisfies the in-
equality N(t) ≤ Λ
µ
.
By adding together the equations of system (3.1.1) we get
dN(t)
dt
= Λ + Λs + Λr + ΛR −N(t)− (dsIs + drIr), t < tmax.
Since Is ≥ 0 and Ir ≥ 0 on the region D
Λ +Λs+ Λr + ΛR+ (µ+dsIs+drIr)N(t) ≤ dN(t)
dt
≤ Λ +Λs+Λr + ΛR−µN(t)
(3.2.1)
for all t < tmax.
Applying standard comparison theorem [6] we obtain
N(0)e−µt+
Λ + Λs + Λr + ΛR
µ+ ds + dr
(1−e−(µ+ds+dr)t) ≤ N(t) ≤ N(0)e−µt+Λ + Λs + Λr + ΛR
µ
(1−e−µt).
(3.2.2)
The first inequality shows that N(t) is separated from the origin, the second
one proves the invariance of D. In fact, if N(0) ≤ Λ+Λs+Λr+ΛR
µ
, then N(t) ≤
Λ+Λs+Λr+ΛR
µ
for all t ≤ tmax. Therefore tmax = +∞ and N(t) ≤ Λ+Λs+Λr+ΛRµ for
all t > 0.
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3.3 Equilibrium points and reproduction
number
An equilibrium point of the model system (3.1.1) satisfies the condition
dS
dt
=
dIs
dt
=
dIr
dt
=
dR
dt
= 0,
that is, S(t) = Sˆ, Is(t) = Iˆs, Ir(t) = Iˆr and R(t) = Rˆ for all t ≥ 0, where
(Sˆ, Iˆs, Iˆr, Rˆ) satisfies the following system

Λ− (µ+ λˆs + λˆr)Sˆ = 0
Λs + λˆsSˆ − δsIˆs = 0
Λr + λˆrSˆ − δrIˆr = 0
ΛR + ksIˆs + krIˆr − µRˆ = 0
(3.3.1)
3.3.1 Disease free equilibrium and basic reproduction
number
At the disease free equilibrium, Iˆr and Iˆs are both equal to zero. Therefore
• If Λr or Λs is not equal to zero, the system (3.1.1) has no disease free
equilibrium. In this case it is not easy to calculate the equilibrium points
as it sufficient to tell whether people are infected through contacts with
infected individuals from within the population or they are infected from
other sources outside the population.
• If Λr = Λs = 0 and ΛR ≥ 0, then system (3.1.1) has a disease free equi-
librium given by E0 = (Λµ , 0, 0,
ΛR
µ
). Notice that the presence of recovered
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individuals at the equilibrium even though there is no disease. In fact,
these individuals were not infected within this population, they were in-
fected by an external source, recovered then moved into this population.
If there is no immigration, there should be no recovered individuals at
the equilibrium. This is the case when ΛR = 0.
The value that R0 takes can indicate the circumstances in which an epidemic
can become endemic. In the influenza context, R0 tells us, on average, the total
number of people that each single infected individual will initiate to influenza
virus during the period of infection in a completely susceptible population.
The reproduction number is used to investigate the existence of equilibria
for the dynamical system and also to discuss the stability of the disease free
equilibrium. To determine R0 for system (3.1.1) we follow a method in [22].
We consider the infection terms; Is and Ir,

dIs
dt
= Λs +
βsIs
N
S − (µ+ ds + ks)Is,
dIr
dt
= Λr +
βrIr
N
S − (µ+ dr + kr)Ir.
(3.3.2)
Let Fn be the vector formed by new infection terms and Vr the vector consti-
tuted of the remaining transfer terms.
Let
F =
[
∂Fni(x0)
∂xj
]
i,j
,
and
V =
[
∂Vri(x0)
∂xj
]
i,j
with xj = Ir or Is.
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We have that
Fn =

Λs + βsIsS/N
Λr + βrIrS/N

and
Vr =

(µ+ ds + ks)Is
(µ+ dr + kr)Ir
 .
Therefore the Jacobian Matrices of Fn and Vr at the DFE are as follows:
F (E0) =

βsΛ
Λ+ΛR
0
0 βrΛ
Λ+ΛR

and
V (E0) =

(µ+ ds + ks) 0
0 (µ+ dr + kr)
 .
Multiplying F (E0) by V −1(E0) we get that
F (E0)V
−1(E0) =

Λβs
(Λ+ΛR)(µ+ds+ks)
0
0 Λβr
(Λ+ΛR)(µ+dr+kr)
 .
Therefore the reproduction number is
R0 = max(R0s, R0r)
where
R0s =
Λβs
(Λ + ΛR)(µ+ ds + ks)
and
R0r =
Λβr
(Λ + ΛR)(µ+ dr + kr)
.
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The biological interpretations of these quantities are as follows. Note that
R0s represents the number of new infections that one individual infected with
the sensitive strain initiates in a completely susceptible population while R0r
represents the number of new infections that one individual infected with the
sensitive strain initiates in a completely susceptible population.
3.4 Endemic equilibrium points
Let Eˆj = (Sˆ, Iˆs, Iˆr, Rˆ), j = r, s be any arbitrary endemic equilibrium point
obtained by setting system (3.1.1) to zero, so that
Λ− (µ+ λˆs + λˆr)Sˆ = 0
Λs + λˆsSˆ − δsIˆs = 0
Λr + λˆrSˆ − δrIˆr = 0
ΛR + ksIˆs + krIˆr − µRˆ = 0
(3.4.1)
where δj = µ+ dj + kj and λˆj =
βj Iˆj
Nˆ
, j = r, s with Nˆ = Sˆ + Iˆs + Iˆr + Rˆ.
It is easy to see that when Λs 6= 0 (resp. Λr 6= 0), then Iˆs 6= 0 (resp. Iˆr 6= 0)
suggesting that for the disease to be eradicated there should be no new infection
from other sources outside the population.
From (3.4.1), we obtain 
Sˆ =
Λ
µ+ λˆs + λˆr
Iˆs =
Λs + λˆsSˆ
δs
Iˆr =
Λr + λˆrSˆ
δr
Rˆ =
ΛR + ksIˆs + krIˆr
µ
(3.4.2)
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Adding together, we obtain
Nˆ =
1
µ
[
ΛR + Λs
µ+ ks
δs
+ Λr
µ+ kr
δr
+ (µ+
µ+ ks
δs
λˆs +
µ+ kr
δr
λˆrSˆ
]
(3.4.3)
Let γj =
µ+ kj
δj
, j = s, r then
Nˆ =
1
µ
[
ΛR + Λsγs + Λrγr + (µ+ γsλˆs + γrλˆr)Sˆ
]
(3.4.4)
On another hand, from the expressions of λˆ′js we obtain λˆjNˆ = βsIˆs, j = s, r,
which with the expressions of Nˆ and Iˆ ′js, imply
1
µ
[
Γ + (µ+ γsλˆs + γrλˆr)Sˆ
]
λˆj =
βj(Λj + λˆjSˆ)
δj
, j = s, r.
where Γ = ΛR + Λsγs + Λrγr. Using the expression of Sˆ, we have (∆rδsλˆs − µβsΛs)λˆr + ∆sδsλˆ
2
s + [(Γ + Λ) δs − (Λ + Λs) βs]µλˆs − µ2βsΛs = 0,
(∆sδrλˆr − µβrΛr)λˆs + ∆rδrλˆ2r + [(Γ + Λ) δr − (Λ + Λr) βr]µλˆr − µ2βrΛr = 0,
(3.4.5)
with ∆j = Γ + Λγj, j = r, s.
To solve the (nonlinear) system (3.4.5) one can either solve the first (linear)
equation of (3.4.5) for λˆr and substitute in the second equation. Alternatively,
one can also solve the second (linear) equation of (3.4.5) for λˆs and substitute
in the first equation. In both cases, the resulting equation is of 4th order and
is difficult to solve.
On that note, we consider a special case where Λr = Λs = 0, then we have
Γ = ΛR and ∆j = ΛR + Λγj, so that equations (3.4.5) become

[
(ΛR + Λγr) λˆr + (ΛR + Λγs) λˆs + (ΛR + Λ) (1−R0s)µ
]
λˆs = 0[
(ΛR + Λγs) λˆs + (ΛR + Λγr) λˆr + (ΛR + Λ) (1−R0r)µ
]
λˆr = 0.
(3.4.6)
Hence the following results are obtained.
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1. If R0s < 1 and R0r < 1, then necessarily λˆs = λˆr = 0 giving the disease
free equilibrium E0 = (Λµ , 0, 0,
ΛR
µ
).
2. If R0s < 1 < R0r, then from the first equation of (3.4.6) we obtain λˆs = 0.
This with the second equation of (3.4.6) imply that λˆr = 0 (leading to E0)
or λˆr = λˆr0 :=
µ (ΛR + Λ) (R0r − 1)
(ΛR + Λγr)
leading the the endemic equilibrium
Eˆr obtained by substituting λˆs = 0 and λˆr = λˆr0 in (3.4.2. The resistant
strain endemic equilibrium Eˆr is given by
Sˆ =
Λ
µ+ λˆr0
Iˆs = 0
Iˆr =
λˆr0Sˆ
δr
Rˆ =
ΛR + krIˆr
µ
(3.4.7)
3. If R0r < 1 < R0s, then from the second equation of (3.4.6) we obtain
λˆr = 0. This with the first equation of (3.4.6) imply that λˆs = 0 (leading
to E0) or λˆs = λˆs0 :=
µ (ΛR + Λ) (R0s − 1)
(ΛR + Λγs)
leading the the endemic
equilibrium Eˆs obtained by substituting λˆr = 0 and λˆs = λˆs0 in (3.4.2).
The sensitive strain endemic equilibrium Eˆs is given by

Sˆ =
Λ
µ+ λˆs0
Iˆs =
λˆs0Sˆ
δs
Iˆr = 0
Rˆ =
ΛR + ksIˆs
µ
(3.4.8)
4. If R0r > 1 and R0s > 1, then either
i. λˆs = λˆr = 0, giving the disease free endemic equilibrium E0, or
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ii. λˆs = 0 and λˆr 6= 0, giving the resistant strain endemic equilibrium
Eˆr, or
iii. λˆr = 0 and λˆs 6= 0, giving the sensitive strain endemic equilibrium
Eˆs, or
iv. λˆr 6= 0 and λˆs 6= 0. In this case we have the following system (ΛR + Λγr) λˆr + (ΛR + Λγs) λˆs + (ΛR + Λ) (1−R0s)µ = 0(ΛR + Λγr) λˆr + (ΛR + Λγs) λˆs + (ΛR + Λ) (1−R0r)µ = 0.
This implies that R0s = R0r (= R0). In this case we have two cases
Note that this are sub-cases of cases from i to iv.
a. If R0r 6= R0s, then there is no endemic equilibria.
b. If R0r = R0s, then
λˆr = λˆ0r − λˆ0r
λˆ0s
λˆs,
In this case system (3.1.1) has a family of endemic equilibria given
by 
Sˆ =
Λ
µ+ λˆs + λˆr0 − λˆr0λˆs0 λˆs
Iˆs =
λˆsSˆ
δs
Iˆr =
(
λˆr0 − λˆ0rλˆs0 λˆs
)
Sˆ
δr
Rˆ =
ΛR + ksIˆs + krIˆr
µ
(3.4.9)
where 0 < λˆs < λˆs0, is arbitrary.
If λr 6= 0 and λs 6= 0 then system (3.1.1) has endemic equilibria. But if λr = 0
and λs = 0 then system (3.1.1) has disease free equilibrium.
The existence of the equilibria is given in the following proposition, where we
assume that λs,Λr = 0.
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Proposition 3.4.1. 1. If R0s < 1 and R0r < 1, then system (3.1.1) has
only one equilibrium point, the disease free equilibrium point, E0.
2. If R0s < 1 < R0r, then in addition to E0 system (3.1.1) has another
equilibrium point, the equilibrium point, Eˆr.
3. If R0r < 1 < R0s, then in addition to E0 system (3.1.1) has another
equilibrium point, the equilibrium point, Eˆs.
4. If R0r > 1 and R0s > 1, and R0r 6= R0s, then system (3.1.1) has three
equilibrium points, E0, Eˆs and Eˆr.
5. If R0r > 1 and R0s > 1, and R0r = R0s, then in addition to E0, Eˆs and
Eˆr, system (3.1.1) has a family of equilibrium points given by (3.4.9).
Figure 3.2: Existence of equilibrium points.
From figure (3.2) we have the following summary of existence of the equilibria
described in proposition (3.4.1).
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• In region A the equilibrium point with the sensitive strain, Eˆs, exists
• In region C the equilibrium point with the sensitive strain, Eˆr, exists
and
• In region B the DFE, E0 exists.
3.5 Stability Analysis of the DFE
The Jacobian Matrix of system (3.1.1) at the disease free equilibrium, E0 =
(Λ
µ
, 0, 0, ΛR
µ
) is given by
J(E0) =

−µ − βsΛ
Λ+ΛR
− βrΛ
Λ+ΛR
0
0 βsΛ
Λ+ΛR
− (µ+ ds + ks) 0 0
0 0 βrΛ
Λ+ΛR
− (µ+ dr + kr) 0
0 ks kr −µ

and its characteristics polynomial is given by
P (x) =
1
(Λ + ΛR)2
(µ+x)2(βsΛ+δsΛ+ΛRx+Λx+δsΛR)(Λx+ΛRx−βrΛ+Λδr+δrΛR).
Solving P (x) = 0, we get x1 = −µ,
x2 =
Λβr
Λ + ΛR
− δr
= δr(R0r − 1).
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x3 =
Λβs
Λ + ΛR
− δs
= δs(R0s − 1).
It is clear that if R0r < 1 and R0s < 1, then all the eigenvalues are negative,
implying that E0 is locally asymptotically stable. Otherwise, at least one of
the eigenvalues is positive, implying that E0 is unstable. As a result we have
the following proposition.
Proposition 3.5.1. If R0r < 1 and R0s < 1, then E0 is locally asymptotically
stable. Otherwise, E0 is unstable.
3.6 Stability analysis of the endemic equilibria
Proposition 3.6.1. If R0r > 1 and R0r > R0s, then the endemic equilibrium
point of system (3.1.1), Eˆr is locally asymptotically stable.
Proof. The eigenvalues of the Jacobian Matrix of system (3.1.1) at the endemic
equilibrium Eˆr are given by
x1 = −µ < 0and
x2 =
(R0s −R0r)δs
R0r
which is negative if and only if R0r > R0s. The other two eigenvalues are given
by the roots of the following quadratic equation
a2x
2 + a1x+ a0 = 0, (3.6.1)
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where 
a2 = (ΛRδr + Λ(µ+ kr))Ror
a1 = µRor(Λ(µ+ kr) + Λδr(R0r − 1) + ΛRδrRor))
a0 = µδr(Ror − 1)(Λ(µ+ kr) + Λδr(Ror − 1) + ΛRδrRor).
If R0r > 1 then the quadratic equation (3.6.1) has positive coefficients which,
by Routh-Hurwitz, criterion implies that the other two eigenvalues have neg-
ative real parts. Thus, if R0s < R0r and R0r > 1, then Eˆr is locally asymptot-
ically stable.
Figure 3.3: Bifurcation diagram in the (R0r, R0s) plane for the following cases:
R0s > 1 and R0s > R0r (Region A), R0s < 1 and R0r < 1 (Region B), R0r > 1 and
R0r > R0s (Region C).
Proposition 3.6.2. If Rs > 1 and R0s > R0r, then the endemic equilibrium,
of system (3.1.1), Eˆs is locally asymptotically stable.
The proof is similar to the one for Eˆr.
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The stability for each equilibrium point is summarized in the bifurcation dia-
gram (3.3).
From bifurcation diagram (3.3) we observe that
• In region A, sensitive strain equilibrium point, Es is locally asymptoti-
cally stable.
• In region B, DFE, E0 is locally asymptotically stable.
• In region C, resistant strain equilibrium point, Er is locally asymptoti-
cally stable.
3.7 Numerical simulations and discussions
In this section, we present some numerical simulation results which illustrate
the effects of not controlling the disease. The model (3.1.1) is simulated using
Python with the parameter values in table (3.2) and the initial conditions
S(0) = 800, Is = 10, Ir = 0, R(0) = 0. Note that due to unavailability of data
we have used the parameters values from [18]. We consider the transmission
parameters βs and βr as free (bifurcation) parameters so that R0s < 1 (resp.
R0r < 1) if and only if βs < β∗s (resp. βr < β∗r ) where
β∗s =
(Λ + ΛR)(µ+ ds + ks)
Λ
,
β∗r =
(Λ + ΛR)(µ+ dr + kr)
Λ
.
(3.7.1)
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Table 3.2: Parameter values used in the simulations for system 3.1.1 taken from
[18]. the unit of all rates is day−1.
Parameter Parameter values
Λ,Λs,Λr,ΛR 9000
µ 0.00005
βs 0.2835
βr 0.2835
dr 0.007− 0.45 [2]
ds 0.007− 0.45 [2]
kr 0.1667
ks 0.1667
When R0 < 1, then the population dynamics of infected individuals are shown
in Figure (3.4). We observe that both resistant and sensitive strains die out.
This confirms the asymptotic stability result of the DFE.
When R0r > 1 and R0r > R0s, the population dynamics of infected individuals
are represented in Figure (3.5). We observe that the number of individuals
infected with the resistant strain increases and reaches the equilibrium point
while that of individuals infected with the sensitive strain decreases and reaches
zero. This confirms the local asymptotic stability result of Er.
When R0s > 1 and R0s > R0r the population dynamics of infected individuals
are represented in Figure (3.6). We observe that the number of individu-
als infected with the sensitive strain increases and reaches the equilibrium
point while that of individuals infected with the resistant strain decreases and
reaches zero. In this case the equilibrium point for sensitive strain is locally
asymptotically stable. This confirms the local asymptotic stability result of
Eˆs.
From Figure (3.7) we observe the population dynamics of the resistant strain
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Figure 3.4: Population dynamics for influenza model without control measures
when R0 < 1.
when taking into consideration different disease induced death rates. We ob-
serve that the number of individuals infected with the resistant strain reaches
the peak on the 95th day and approximately 300000 individuals die due to the
disease. After that it declines and have another peak lower than the first one
on the 195th day and also on the 199th day and becomes stable after the 200th
day. This shows that without the control measures the mortality rate due to
the disease will increase dramatically. So it is important to implement control
measures such as treatment and vaccination.
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Figure 3.5: Population dynamics for influenza model without control measures
when R0r > 1 and R0r > R0s.
It is clear that when R0s > 1 or R0r > 1, (interventions such as treatment and
vaccination are not implemented) the disease will just continue to spread. In
the next chapter we shall demonstrate the impact of antiviral treatment and
vaccination in eradicating the spread of influenza.
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Figure 3.6: Population dynamics for influenza model without control measures
when R0s > 1 and R0s > R0r.
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Figure 3.7: Population dynamics for influenza model without control measures
considering the different disease induced death rates, dr.
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Chapter 4
Influenza model with vaccination
and antiviral treatment
4.1 Model formulation
We extend the model in chapter 3 to incorporate control measures such as
treatment and vaccination. For this the class for the sensitive strain is divided
into two classes: Isu for untreated individuals and Ist for treated ones. To
account for vaccination, we distinguish between susceptible individuals who
are vaccinated, V and those who are not, S. With this, the total population
becomes
N = S + V + Isu + Ist + Ir +R.
Susceptible individuals are assumed to be vaccinated at a per-capita rate ν
with immunity waning (immunity decreases gradually) at per-capita rate σ. A
fraction f of individuals infected with the sensitive strain receive treatment.
38
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The transmission rate for an individual who received treatment will be reduced
by a factor δ.
Table 4.1: Description of parameters and variables for the model with control
measures
Parameter Description
Isu Individuals infected with the sensitive strain and untreated.
Ist Individuals infected with the sensitive strain an treated.
V Vaccinated individuals.
ν Rate at which susceptible individuals are vaccinated.
σ Rate at which individuals lose vaccine-induced immunity.
ω Rate at which individuals lose immunity acquired by infection.
δ Reduction factor in infectiousness due to the antiviral treatment.
f Fraction of new infected individuals who are treated.
ksu Recovery rate of individuals infected with the sensitive strain and untreated.
kst Recovery rate of individuals infected with the sensitive strain and treated.
dsu Death rate due to sensitive untreated strain.
Susceptible population is increased through recruitment of individuals either
by immigration or birth at the rate Λ. Susceptible individuals exit the com-
partment S and enter the following compartments: V for vaccinated individ-
uals (at a rate ν), the class of individuals infected with the sensitive strain
who are not treated Isu (at a rate (1− f)λs), the individuals infected with the
sensitive strain being treated Ist (at a rate fλs) and individuals infected with
the resistant strain Ir (at a rate λr). There is a possibility that susceptible
individuals die due to natural causes at a rate µ.
Vaccinated individuals may die due to natural causes at a rate µ and there is
a possibility that they revert to the susceptible class S at a rate σ. Untreated
individuals can either die due to natural causes at a rate µ or due to influenza
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at a rate dsu. Treated individuals can either die due to natural causes at a
rate µ or progress to a recovered class R at a rate kst. Individuals infected
with the resistant strain can recover naturally at a rate kr, they can also die
due to influenza at a rate dr or due to natural causes at a rate µ. Recovered
individuals can loose immunity at a rate ω or die due to natural causes at a
rate µ.
The model diagram describing the flows between the model’s compartments is
given in figure (4.1).
Figure 4.1: The model diagram of influenza with vaccination and antiviral treat-
ment where λs =
βsIsu + δβsIst
N
and λr =
βrIr
N
.
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Notice that in this model we ignore the recruitment rates into the recovered and
infected classes. The model’s parameters and variables related to treatment
and vaccination are described in table 4.1. The remaining parameters and
variables are the same as in Chapter 3. Based on the above model’s diagram,
we have the following system of differential equations:

dS
dt
= Λ− (µ+ ν)S − λsS − λrS + ωR + σV,
dV
dt
= νS − (σ + µ)V,
dIsu
dt
= (1− f)λsS − (µ+ dsu)Isu − ksuIsu,
dIst
dt
= fλsS − kstIst − µIst,
dIr
dt
= λrS − (µ+ dr)Ir − krIr,
dR
dt
= ksuIsu + kstIst + krIr − (µ+ ω)R.
(4.1.1)
4.1.1 Positivity and boundedness of solutions
Since influenza model monitors the dynamics of the human population it is
important that all the model variables stay positive at all times. We introduce
a region of feasibility Ω.
Ω =
{
(S, V, Isu, Ist, Ir, R) ∈ R6+ : S + V + Isu + Ist + Ir +R ≤
Λ
µ
}
.
Proposition 4.1.1. Let S(0) ≥ 0, V (0) ≥ 0, Isu(0) ≥ 0, Ist(0) ≥ 0, Ir(0) ≥ 0,
R(0) ≥ 0 and assume that Λ > 0. Then the corresponding solution S, V, Isu, Ist, Ir, R
of system (4.1.1) is positive. Furthermore, the region Ω is positively invariant
that is all solutions starting in Ω remain in Ω for all time t ≥ 0.
(The proof is similar to the one in Chapter 3)
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4.2 Equilibrium points and reproduction
number
4.2.1 Equilibrium points
To determine the equilibrium points of the system (4.1.1) we need to solve
simultaneously the following equations
0 = Λ− (µ+ ν)S − λsS − λrS + ωR + σV,
0 = νS − (σ + µ)V,
0 = (1− f)λsS − (µ+ dsu)Isu − ksuIsu,
0 = fλsS − kstIst − µIst,
0 = λrS − (µ+ dr)Ir − krIr,
0 = ksuIsu + kstIst + krIr − (µ+ ω)R.
(4.2.1)
4.2.2 Disease free equilibrium
In the absence of influenza infection, system (4.2.1) becomes 0 = Λ− (µ+ ν)S + σV,0 = νS − (σ + µ)V. (4.2.2)
By solving system (4.2.2) we obtain the disease free equilibrium given by
E0 = (S0, V0, 0, 0, 0, 0)
where
S0 =
(σ+µ)Λ
µ(σ+µ+ν)
,
V0 =
νΛ
µ(σ+µ+ν)
.
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representing the numbers of susceptible individuals and vaccinated individuals,
respectively, in the absence of influenza infection.
To find the other equilibria, we first determine the reproduction number, R0C
of the dynamical system (4.1.1) (The subscript C denotes the combined inter-
ventions, treatment and vaccination). For this we follow the same method as
in chapter 3. We consider the infection terms: Isu, Ist, and Ir. After similar
algebraic procedure as in chapter 3 we obtain
R0C = max(R0sC , R0rC),
where 
R0sC =
σ + µ
σ + µ+ ν
R
0s
,
R0rC =
σ + µ
σ + µ+ ν
R0r
(4.2.3)
with 
R0s = (1− f)R0su + fR0st
R0su =
βs
µ+ ksu + dsu
,
R0st =
βsδ
µ+ kst
,
R0r =
βr
µ+ kr + dr
.
(4.2.4)
The biological interpretations of these quantities are as follows:
The quantities R0st and R0su represent the number of secondary sensitive cases
produced by a treated and untreated sensitive case, respectively, during the
period of infection in a susceptible population.
Each sensitive case may either receive treatment with probability f or remain
untreated with probability 1 − f. The quantity R0sC represents the number
of secondary sensitive cases produced by a typical sensitive case during the
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period of infection in a population where control measures (vaccination and
treatment) are implemented.
Similarly, the quantity R0r represents the number of secondary resistant cases
produced by a resistant case during the period of infection in a completely
susceptible population. Thus, the quantity R0rC (where r is for resistant and
C is for control) represents the number of secondary resistant cases produced
by a typical resistant case, that is, the control reproduction number for the
resistant strain, during the period of infection in a population.
By [22], we state the local stability of the DFE in the following theorem.
Theorem 4.2.1. The DFE, E0 is locally asymptotically stable if and only if
R0C < 1.
4.2.3 Endemic equilibrium points
In the presence of treatment we have system (4.2.1). Solving system (4.2.1)
simultaneously we get 
Vˆ =
νSˆ
σ + µ
,
Iˆsu =
(1− f)λˆsSˆ
µ+ dsu + ksu
Iˆst =
fλˆsSˆ
kst + µ
Iˆr =
λˆrSˆ
µ+ dr + kr
Rˆ =
ksuIˆsu + kstIˆst + krIˆr
µ+ ω
,
(4.2.5)
where
Sˆ =
Λ (kst + µ) (µ+ dsu + ksu) (µ+ dr + kr) (µ+ ω) (σ + µ)
A+ Arλˆr + Asλˆs
(4.2.6)
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with
A = µ (kst + µ) (µ+ dsu + ksu) (µ+ dr + kr) (µ+ ω) (µ+ ν + σ) ,
Ar = (kst + µ) (µ+ dsu + ksu) (σ + µ) (µ
2 + µdr + µω + µkr + drω)
As = (µ+ dr + kr) (σ + µ)
 ω (µ2 + µdsu + µksuf + (1− f)µkst + (1− f) kstdsu)
+µ (kst + µ) (µ+ dsu + ksu)
 .
Adding together the right hand side of (4.2.5), we obtain
Nˆ = Sˆ
[
σ + µ+ ν
σ + µ
+ (
(1− f)(µ+ ω + ksu)
(µ+ dsu + ksu)(µ+ ω)
+
f(µ+ ω + kst)
(kst + µ)(µ+ ω)
)λˆs +
µ+ ω + kr
(µ+ kr + dr)(µ+ ω)
λˆr
]
.
Substituting the expression of Nˆ into λˆs =
βsIˆsu + δβsIˆst
Nˆ
and λˆr =
βrIˆr
Nˆ
, we
obtain the solutions of the following system
[
γrλˆr + γsλˆs + (1−R0rC)
]
λˆr = 0[
γrλˆr + γsλˆs + (1−R0sC)
]
λˆs = 0
(4.2.7)
where
γr =
µ+ ω + kr
(µ+ ω) (µ+ dr + kr)
[
(µ+ σ)
σ + µ+ ν
]
γs =
(µ+ ksu) (µ+ kst) + f (dsu (kst + µ+ ω) + ksuω) + µω + (1− f) kstω
(kst + µ) (µ+ dsu + ksu) (µ+ ω)
[
(µ+ σ)
σ + µ+ ν
]
.
Thus
1. If R0rC < 1 and R0sC < 1, then necessarily λˆs = λˆr = 0. Hence we have
the DFE, E0 = (S0, V0, 0, 0, 0, 0).
2. If R0rC > 1 and R0sC < 1, then from the second equation of system
(4.2.1) we obtain λˆs = 0. This, together with the first equation of (4.2.1)
imply that λˆr = 0 (leading to DFE) or
λˆr =: λˆ0r =
(R0rC − 1)(σ + µ+ ν)(µ+ dr + kr)(µ+ ω)
(σ + µ)(µ+ ω + kr)
.
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Substituting λˆs = 0 and λˆr = λˆ0r, into system (4.2.5), we obtain the
endemic equilibrium Eˆr given by
Vˆ =
νSˆ
σ + µ
,
Iˆsu = Iˆst = 0,
Iˆr =
λˆ0rSˆ
µ+ dr + kr
Rˆ =
krIˆr
µ+ ω
,
(4.2.8)
where Sˆ, is defined in equation (4.2.6).
3. If R0rC < 1 and R0sC > 1, then from the first equation of system (4.2.1)
we obtain λˆs = 0, this together with the second equation of (4.2.1) imply
that λˆs = 0 (leading to DFE) or
λˆ0s =
(R0sC − 1)(µ+ dsu + ksu)(µ+ ω)(µ+ kst)
(1− f)(µ+ ω + ksu)(µ+ kst)(µ+ ω) + f(µ+ dsu + ksu)(µ+ ω + kst) .
Substituting λˆr = 0 and λˆs = λˆ0s into system (4.2.5) we obtain the
endemic equilibrium Eˆs given by
Vˆ =
νSˆ
σ + µ
,
Iˆsu =
(1− f)λˆ0sSˆ
µ+ dsu + ksu
,
Iˆst =
fλˆ0sSˆ
kst + µ
,
Iˆr = 0,
Rˆ =
ksuIˆsu + kstIˆst
µ+ ω
.
(4.2.9)
4. If R0rC > 1 and R0sC > 1, then either
i. λˆr = λˆs = 0, giving the DFE or
ii. λˆs = 0 and ˆλr 6= 0, giving the resistant strain endemic equilibrium, Eˆr
or
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iii. λˆs 6= 0 and λˆr = 0, giving the sensitive strain endemic equilibrium, Eˆs
or
iv. λˆs 6= 0 and λˆr 6= 0; in this case we have the following system
 γrλˆr + γsλˆs + (1−R0rC) = 0γrλˆr + γsλˆs + (1−R0sC) = 0. (4.2.10)
This implies that R0sC = R0rC = R0C . In this case we have two cases:
a. If R0sC 6= R0rC , then there is no endemic equilibria.
b. If R0sC = R0rC , then
λˆr =
R0C − 1− γs
γr
.
In this case system (4.2.1) has a family of endemic equilibria given by
Vˆ =
νSˆ
σ + µ
,
Iˆsu =
(1− f)λˆsSˆ
µ+ dsu + ksu
Iˆst =
fλˆsSˆ
kst + µ
Iˆr =
(R0C − 1− γs)Sˆ
γr(µ+ dr + kr)
Rˆ =
ksuIˆsu + kstIˆst + krIˆr
µ+ ω
.
(4.2.11)
4.3 Bifurcation diagrams and their
interpretation
The threshold conditions determined by R0sC and R0rC can be rewritten using
f and ν, which will make it more easy to understand the impact of varying
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Figure 4.2: Bifurcation diagram in the (f, ν), plane for the cases R0C < 1, (Region
A), R0sC > 1 and R0rC < 1, (Region B) and R0sC > 1 and R0rC > 1 (Region C).
the treatment and vaccination rates. R0sC < 1 if and only if
ν > (σ + µ) [R0su − 1− f(R0su −R0st)] := ν∗s (f) (4.3.1)
and R0rC < 1 if and only if
ν > (σ + µ)(R0r − 1) := ν∗r . (4.3.2)
The proportion ν∗r increases linearly with σ and R0r. This means that when σ
is high (waning effect is high) we need to vaccinate more people. The same
applies to R0r. In fact, when R0r is high, more people are expected to be
infected with the resistant strain. In this case it is necessary to vaccinate higher
proportion of susceptible individuals to prevent them from being infected with
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Figure 4.3: Bifurcation diagram in the (f, ν) plane for the cases R0C > 1 and
ν < ν∗r and ν < ν∗s (f) (Region A and G), R0sC < 1 and R0rC > 1 and ν < ν∗r
and ν > ν∗s (f) (Region B) and R0sC > 1 and R0rC > 1 and ν > ν∗r and ν > ν∗s (f)
(Region C) and R0sC > 1 and R0rC < 1 (Region D).
the resistant strain.
Moreover, ν∗s (f) is the minimal value to be vaccinated when individuals are
exposed to the sensitive strain only. This value decreases linearly with the
rate at which people are treated, f, as well as R0su − R0st which is the the
reduction in the basic reproductive number of the sensitive strain that is due
to treatment.
To carry out a bifurcation analysis of (4.1.1) we assume that treatment reduces
the basic reproductive number of the sensitive strain, that is R0st < R0su. We
distinguish the following cases:
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Figure 4.4: Bifurcation diagram in the (f, ν) plane for the cases R0C > 1 and
ν < ν∗r and ν < ν∗(f) (Region A), R0sC < 1 and R0rC > 1 and ν < ν∗r and
ν > ν∗(f) (Region B) and R0sC < 1 and R0rC < 1 and ν > ν∗r and ν > ν∗(f)
(Region C).
1. R0r < R0st : represented in Figure 4.2.
2. R0st < R0r < R0su : represented in Figure 4.3.
3. R0su < R0r : represented in Figure 4.4.
From bifurcation diagram (4.2) we observe that in region A, ν > ν∗s (f) and
ν > ν∗r , implying that R0sC < 1 and R0rC < 1. Therefore, the DFE is stable
implying that there is no influenza infection at all. In region B, Eˆr exists
and it is stable. In region C, both sensitive and resistant strains exist, since
R0r < R0s, the sensitive strain (the one with the higher reproduction number)
is stable.
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From bifurcation diagram (4.4) we observe that in region A, both strains exist
with the resistant strain (the one with the higher reproduction number) being
stable. In region B, Eˆr is locally asymptotically stable. Finally in region C,
the DFE is stable.
From bifurcation diagram (4.3) we observe that in region C, the DFE is stable.
In region B, the resistant strain, Eˆr exists and it is locally asymptotically sta-
ble. In region D, the sensitive strain, Eˆs exists and it is locally asymptotically
stable. In region A and G, both resistant and sensitive strains exist, but only
the one with the higher basic reproductive number will be stable.
Notice that the two lines ν∗s (f) and ν∗r , intersect at f
∗ =
R0su −R0r
R0su −R0st and that
when f > f ∗ (resp. f < f ∗) we have R0r < R0s (resp. R0r > R0s). There-
fore, in region A (f > f ∗), Eˆr is the one that is stable while in region G, the
equilibrium point Eˆs is stable.
4.4 Numerical simulations and discussions
In this section we present some numerical results which extend the mathemat-
ical analysis results and illustrate the impact of two important factors on con-
trolling the disease. That is the rate at which susceptible individuals are vacci-
nated and the fraction of new sensitive strain cases being treated. We also con-
firm the stability of the equilibrium points numerically. We consider the follow-
ing initial condition S(0) = 8000, V (0) = 2000, Isu(0) = 200, Ist = 0, R(0) = 0
for model (4.1.1).
According to CDC 2008 [2], the immunity obtained from vaccination lasts
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Table 4.2: Parameter values used in the simulations for system 4.1.1.
Parameter Parameter values
ν 0.001− 0.50
σ 0.003
ω 0.003
δ 0.4
f 0.0− 0.9
ksu 0.1667
kst 0.1667
about one year, assuming that the average length of immunity induced by
vaccine and by infection are the same, we choose σ = ω = 0.003(days−1). We
consider different values of vaccination rate and treatment.
Note that for all the numerical simulations we consider the parameter values in
Table (4.2) and only check the impact of antiviral treatment and vaccination
by considering different values of f, ν.
When R0C < 1, the population dynamics of infected individuals are repre-
sented in Figure (4.5). We observe that individuals infected with the sensitive
strain (treated and untreated) and individuals infected with the resistant strain
vanish, implying that the influenza virus dies out as time goes on. This is also
shown in the bifurcation diagrams 4.2 and 4.4 in region A and C respectively.
Therefore DFE is locally asymptotically stable when R0C < 1.
When R0sC > 1 and R0rC < 1, the population dynamics of infected individuals
are represented in Figure (4.6). We observe that individuals infected with the
sensitive strain increase and reach their equilibrium point while the individuals
infected with the resistant strain decrease and reach its equilibrium point. This
is shown in the bifurcation diagram in figure 4.2 in region B. In this case, the
equilibrium point for sensitive strain is locally asymptotically stable.
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Figure 4.5: Population dynamics of system (4.1.1) when R0C < 1 with the param-
eter values in Table 4.2 except that βr = βs = 0.02835.
When R0sC < 1 and R0rC > 1, the population dynamics of infected individuals
are represented in Figure (4.7). We observe that the number of individuals in-
fected with the resistant strain increase and reach their equilibrium point while
the number of individuals infected with the sensitive strain decrease and reach
its equilibrium point. In this case the equilibrium point for resistant strain is
locally asymptotically stable. This is shown in the bifurcation diagrams 4.3
and 4.4 both in region B.
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Figure 4.6: Population dynamics of system (4.1.1) when R0sC > 1 and R0rC < 1,
with the parameter values in Table 4.2 except that βr = 0.0002835 and βs = 0.2835.
When R0sC > 1 and R0rC > 1, the transmission dynamics of infected individ-
uals are represented in Figures (4.8). We observe that when the transmission
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Figure 4.7: Population dynamics of system (4.1.1) when R0sC < 1 and R0rC > 1,
with the parameter values in Table 4.2 except that βr = 3.009 and βs = 0.2835.
rates are equal and the treatment is not implemented both strains will per-
sist. This means that the two endemic equilibria for both strains are locally
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Figure 4.8: Population dynamics of system (4.1.1) when R0sC > 1 and R0rC > 1,
with the parameter values in Table 4.2 except that f = 0, βr = 0.02835 and βs =
0.2835.
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asymptotically stable as shown in Figure 4.3 region C.
In Figure (4.9) the population dynamics for both sensitive and resistant strain
when R0sC < 1 and R0rC > 1, considering different values of f. We observe
that when 50% of the susceptible individuals is treated, then the number of
individuals infected with the sensitive strain will decrease while the number of
individuals infected with the resistant strain increases and reaches its equilib-
rium point. This means that the resistant strain equilibrium point is locally
asymptotically stability.
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Figure 4.9: Population dynamics of system (4.1.1) considering different values of
f.
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Chapter 5
Discussion and concluding remarks
In this study we considered two compartmental models for influenza with sen-
sitive and resistant strains. The first model considered a population which is
divided into four disjoint classes: susceptible individuals, individuals infected
with the sensitive strain, individuals infected with the resistant strain and
recovered individuals. The second model considered a population which is di-
vided into six disjoint classes: In addition to the ones for the first model we
considered the class of individuals infected with the sensitive strain which is di-
vided into two classes: untreated individuals and treated ones and vaccinated
individuals.
We reviewed several recent studies on the influence of different influenza pre-
vention and control measures including vaccination and antiviral treatment.
In this study we considered the use of antiviral treatment and vaccination as
the control measures in order to gain more insights on the implementation of
control measures of influenza among human population.
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In Chapter 3 we have developed and analysed a compartmental model that
describes the transmission dynamics of influenza where control measures such
as quarantine, vaccination and treatment are not implemented. We considered
the resistant and sensitive strains, and a constant recruitment into each class.
This model is the modification of the model in the "Modelling and analysis of
influenza A (H1N1) on networks" [13] whereby only the transmission dynamics
of influenza between susceptible, exposed, asymptotic, infected and recovered
individuals were considered, but without considering the sensitive and resistant
strains or emergency strain that may cause death.
The numerical analysis showed that when the basic reproduction numbers of
both strains are less than one the two strains will die out. When at least one
of the basic reproduction numbers is greater than one, the strain with the
higher basic reproduction number is the one that will persists. In general, the
sensitive strain is the one that is more dominant, but it can be eliminated by
treatment. It has been shown mathematically that the DFE will be locally
asymptotically stable when both basic reproduction numbers of both strains
are less than one. Also, when at least one of the basic reproduction numbers is
greater than one, the strain with the higher basic reproduction number is that
one that will be locally asymptotically stable. These has also been confirmed
using bifurcation theory.
In Chapter 4 we extended the model in Chapter 3 in order to incorporate
antiviral treatment and vaccination. The numerical analysis showed that the
more susceptible individuals get treated the more the number of individuals
infected with the resistant strain increases, these imply that higher levels of
treatment may lead to an increase of epidemic, and the extend to which this
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occurs depends on the other factors like the rates of resistance development
and vaccination. This suggests that vaccination and antiviral treatment should
be implemented appropriately. The resistant strain might be due to the new
strain or unknown strain or emergence strain during the cause of the outbreak,
and obviously when the new strain emerges we can not get the appropriate
treatment as soon as possible. So it is important for us to gain more insights
on how we can prepare for any new strain. These can be controlled by vacci-
nating as many people as possible before the outbreak starts. We also applied
bifurcation theory to show the stability of endemic equilibria using the re-
production numbers and taking into consideration the effect of treatment and
vaccination. The bifurcation results corresponds with what we have observed
in the numerical simulations.
The model with vaccination and treatment can be extended in order to in-
corporate some more control measures such as quarantine, isolations, media
coverage and new strain.
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